Also known as: Yale
GE HealthCare expanded a BARDA deal by $35M for AI ultrasound; Wavelet Medical partnered with Aegis Ventures to advance AI fetal EEG. Both aim to improve diagnostic speed and accuracy.
Anterior raised $40M to accelerate health plan AI adoption, bringing total funding to $64M. Other deals include Findhelp's $250M investment, Grow Therapy's $150M Series D, and Bexorg's $23M Series A.
Yale researchers built genomic AI models for personalized medicine. The University of Liverpool and BPGbio will expand AI drug discovery via the NAi platform.
Trump administration cuts to U.S. science funding have raised fears of a brain drain, with thousands of grants cancelled and researchers moving abroad. Experts warned the losses could damage biomedical innovation and the economy.
The FDA approved acalabrutinib combined with venetoclax for chronic lymphocytic leukemia and small lymphocytic leukemia based on phase III trial results. Separately, Yale researchers identified CD25 protein complex as a new drug target for aggressive leukemias.
U.S. regulators have received more than 1,400 reports since 2021 involving AI-enabled surgical devices, including allegations of botched surgeries and misidentified body parts. The FDA has authorized over 1,300 AI-integrated medical devices.
